Soluble receptor for advanced glycation end-product (sRAGE)/pentosidine ratio: a potential risk factor determinant for Type 2 diabetic retinopathy
This study aims to investigate potential diabetic retinopathy (DR) risk factors by evaluating the circulating levels of pentosidine, soluble receptor for advanced glycation end-product (sRAGE), advanced oxidation protein product (AOPP) as well as glutathione peroxidase (GPx) and superoxide dismutase...
Main Authors: | Ng, Z.X., Chua, K.H., Iqbal, T., Kuppusamy, U.R. |
---|---|
Format: | Article |
Language: | English |
Published: |
2013
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/8170/1/Ng-2013-Soluble_Receptor_for.pdf |
Similar Items
-
Receptor for advanced glycation end-product (RAGE) gene polymorphism 2245G/A is associated with pro-inflammatory, oxidative-glycation markers and sRAGE in diabetic retinopathy
by: Ng, Z.X., et al.
Published: (2013) -
Association analysis of-429T/C and-374T/A polymorphisms of receptor of advanced glycation end products (RAGE) gene in Malaysian with type 2 diabetic retinopathy
by: Ng, Z.X., et al.
Published: (2012) -
2245G/A polymorphism of the receptor for advanced glycation end-products (RAGE) gene is associated with diabetic retinopathy in the Malaysian population
by: Ng, Zhi Xiang, et al.
Published: (2012) -
Lack of association between Gly82Ser, 1704G/T and 2184A/G of RAGE gene polymorphisms and retinopathy susceptibility in Malaysian diabetic patients
by: Ng, Z.X., et al.
Published: (2012) -
Attenuated levels of pro-inflammatory markers in diabetic retinopathy patients undergoing treatment with antihyperglycemic and antihypertensive drugs
by: Ng, Z.X., et al.
Published: (2013)